Showing 37 - 38 of 38 results
Previous| 1... 2 | 3 | 4 |Next
FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park.
Clinical Trial Takes Aim at Promising Target in Advanced Gastric, Pancreatic Cancers
BROADCASTMED